Safety and Effectiveness of CD4-IgG2 in HIV-Positive Children
NCT00000876
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
NIH
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
CD4-IgG2
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
[object Object]